id	keyword
dpc-3517	patients
dpc-3517	melanoma
dpc-3517	pembrolizumab
dpc-3517	pediatric
dpc-3517	group
dpc-3517	hdi
dpc-3517	adjuvant
dpc-3517	grade
dpc-3517	therapy
dpc-3517	study